Literature DB >> 16162153

Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers.

Xiao-Bo Man1, Liang Tang, Bao-Hua Zhang, Shen-Jing Li, Xiu-Hua Qiu, Meng-Chao Wu, Hong-Yang Wang.   

Abstract

BACKGROUND/AIM: Expression alteration of Glypican-3 (GPC3) is associated with several malignancies and has been identified as an overexpressed gene in hepatocellular carcinoma (HCC). In this study GPC3 expression in intrahepatic chanlangiocarcinoma (ICC), gallbladder cancer and HCC was quantitatively detected.
METHODS: Real-time quantitative reverse transcription polymerase chain reaction was used to detect the expression level of GPC3.
RESULTS: GPC3 expression was elevated more than two-fold in HCC compared with adjacent tissue in 90 of 100 HCC cases. The average expression level of GPC3 was significantly higher in HCC than that in adjacent liver tissues (P<0.0001). Only in four of 21 ICC cases GPC3 expression was upregulated more than two-fold in tumor tissues. GPC3 expression was downregulated in gallbladder cancer in 12 of 13 cases and the average expression level was significantly lower than that in normal gallbladder tissues (P<0.05).
CONCLUSION: The different expression patterns of GPC3 in HCC and ICC suggested that it might play a different role in theses tumors and could serve as a biomarker for differential diagnosis of HCC and ICC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162153     DOI: 10.1111/j.1478-3231.2005.01100.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  16 in total

Review 1.  Glypican-3: a new target for cancer immunotherapy.

Authors:  Mitchell Ho; Heungnam Kim
Journal:  Eur J Cancer       Date:  2010-11-26       Impact factor: 9.162

2.  Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.

Authors:  Chris K Sun; Mei-Sze Chua; Jing He; Samuel K So
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

3.  Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.

Authors:  Tong-Chun Xue; Bo-Heng Zhang; Sheng-Long Ye; Zheng-Gang Ren
Journal:  Tumour Biol       Date:  2015-02-26

4.  Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.

Authors:  Mei-Yu Hsu; Sherry A Rovinsky; Chiou-Yan Lai; Shadi Qasem; Xiaoming Liu; Joan How; John F Engelhardt; George F Murphy
Journal:  Lab Invest       Date:  2008-06-16       Impact factor: 5.662

5.  Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms.

Authors:  Dalia Rifaat Al-Sharaky; Sheren Fouad Younes
Journal:  J Clin Diagn Res       Date:  2016-03-01

6.  Impaired autophagy response in human hepatocellular carcinoma.

Authors:  Lili Bao; Partha K Chandra; Krzysztof Moroz; Xuchen Zhang; Swan N Thung; Tong Wu; Srikanta Dash
Journal:  Exp Mol Pathol       Date:  2013-12-23       Impact factor: 3.362

7.  Evaluation of asymmetric immunoliposomal nanoparticles for cellular uptake.

Authors:  Jeremiah Whittenton; Ramanan Pitchumani; Sundararajah Thevananther; Kishore Mohanty
Journal:  J Microencapsul       Date:  2012-06-28       Impact factor: 3.142

8.  Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors.

Authors:  Olga Y Burenina; Natalia L Lazarevich; Inna F Kustova; Daria A Shavochkina; Ekaterina A Moroz; Nikolay E Kudashkin; Yuriy I Patyutko; Alexey V Metelin; Eduard F Kim; Dmitry A Skvortsov; Timofei S Zatsepin; Maria P Rubtsova; Olga A Dontsova
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-12       Impact factor: 4.553

9.  Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.

Authors:  Gokce Askan; Vikram Deshpande; David S Klimstra; Volkan Adsay; Carlie Sigel; Jinru Shia; Olca Basturk
Journal:  Am J Clin Pathol       Date:  2016-07-17       Impact factor: 2.493

10.  Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE.

Authors:  Hui Dong; Xijin Ge; Yan Shen; Linlei Chen; Yalin Kong; Hongyi Zhang; Xiaobo Man; Liang Tang; Hong Yuan; Hongyang Wang; Guoping Zhao; Weirong Jin
Journal:  BMC Med Genomics       Date:  2009-01-26       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.